Flexsum Product Overview
"AI-based musculoskeletal function assessment that measures body posture alignment and major joint movements within 2 minutes"
Product Overview
Flexsum is an FDA Class II equivalent medical device certified AI-based musculoskeletal screening equipment that precisely measures full-body alignment and major joint movements in just 2 minutes through a non-invasive method.
Measurement Items
Full-Body Alignment Status
Captures the entire body from frontal, left lateral, and right lateral angles to quantitatively assess joint and body balance status.
Shoulder Range of Motion (ROM)
Measures the range of motion for both shoulders to evaluate movement limitations and asymmetry.
Posture Alignment and Asymmetry
Analyzes balance status of major joints including shoulders, pelvis, and knees for early detection of musculoskeletal imbalances.
Product Specifications
| Item |
Details |
| Form Factor |
All-in-one kiosk (integrated 2D camera, speaker, set-top box, 27-inch display) |
| Installation Space |
2m × 2m |
| Assessment Time |
Approximately 2 minutes |
| Operation Mode |
Semi-automated contactless assessment (1 coordinator can operate multiple units) |
| Result Delivery |
Instant generation and transmission to screening center |
| Certification |
Class II medical device manufacturing certification (April 2026), GMP certified |
Key Features
1. AI-Based Precision Analysis
- AI model trained on over 700,000 data points
- Average accuracy improvement of 18.9% compared to Google MoveNet (shoulder 32.6%, knee 14.6%)
- Medically-validated 24 joint-point pose estimation model (patent registered)
2. Safe and Efficient Assessment
- Low-cost, low-risk non-invasive method compared to X-ray and MRI
- High throughput with 2-minute completion time
- Minimal labor burden through semi-automated operation
3. Screening Center-Optimized Design
- Easy installation within existing screening center flow and space (2m × 2m)
- Measurement items that meet assessment needs across all industries
- Minimized medical dispute risk (no diagnostic function, preventive screening only)
4. Adopted by Korea's Largest Screening Network
Officially implemented as a screening item across all 8 KMI Korea Medical Institute centers nationwide on May 12, 2026.
Implementation Benefits
For Screening Centers
- Identify musculoskeletal health risk clients → link to orthopedic care for potential patient acquisition and revenue growth
- Reduce medical staff workload and improve clinical efficiency through measurement automation
- Strengthen competitiveness with AI-based differentiated services
For Corporate Workplaces
- Implement musculoskeletal disease prevention programs (Industrial Safety and Health Act compliance)
- HR risk management and workforce loss prevention
- ESG value realization and employee welfare enhancement
Technical Excellence(EverEx)
- 57 patent filings (18 registered, 37 PCT)
- International conference validation (CVPR 2025, 2026, ICCV 2025)
- Co-developed with Seoul National University orthopedic specialist CEO and Korea's largest screening institution
Flexsum is a screening center-specialized smart healthcare solution that supports healthy daily life through early detection and prevention of musculoskeletal disorders.